Ascensia Diabetes Care announced today that it launched its online diabetes management and analytics platform in the U.S. Parsippany, New Jersey-based Ascensia now offers GlucoContro.online in more than 15 countries around the world. It plans for further expansion, too. Get the full story at our sister site, Drug Delivery Business News.
Patient Monitoring
iRhythm stock dives on reduced full-year guidance
iRhythm Technologies (Nasdaq:IRTC) shares took a hit after hours today on mixed third-quarter results that compared to the consensus forecast. Shares of IRTC nosedived 17.1% to $105.09 apiece after the market closed. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up 2.1%. (UPDATE: After […]
Health Canada licenses Medtronic next-gen MiniMed 780G insulin pump
Medtronic (NYSE:MDT) Canada announced today that Health Canada granted a license to its MiniMed 780G automated insulin delivery system. The company designed its MiniMed 780G advanced hybrid closed-loop insulin pump system to automatically adjust and correct sugars every five minutes. According to Medtronic, it marks the first and only insulin pump system in Canada to […]
Here’s what diabetes tech companies are doing for National Diabetes Awareness Month
As we enter November, we enter National Diabetes Awareness Month. A number of diabetes technology developers plan to mark that in a special way. Dexcom (Nasdaq:DXCM), Insulet (Nasdaq:PODD) and Embecta (Nasdaq:EMBC) all announced their plans to celebrate. Last year, a handful of companies marked the month — which includes World Diabetes Day (Nov. 14) — […]
Medtronic study highlights need for standardized post-stroke pathways
Medtronic (NYSE:MDT) today announced results from a study of post-stroke workflow protocols and cardiac monitoring. The DiVERT Stroke clinical study demonstrated that the protocols and monitoring vary significantly across community hospitals and academic centers. Medtronic presented data today at the 14th World Stroke Congress in Singapore. Medtronic’s first-of-its-kind, multi-center study evaluated more than 7,600 cryptogenic, large-artery […]
Abbott FreeStyle Libre named ‘best medical technology’ in last 50 years by Galien Foundation
Abbott (NYSE:ABT) announced today that the Galien Foundation picked its FreeStyle Libre continuous glucose monitor (CGM) for a major award. The foundation named FreeStyle Libre as the best “Best Medical Technology” of the last 50 years. Other medtech receiving the designation included Edwards Lifesciences’ Sapien 3 Ultra TAVR and Roche’s Cobas HPV test. This announcement […]
Dexcom stock rises on Q3 results following G7 international rollout
Dexcom (Nasdaq:DXCM) shares are up today — a day after it reported third-quarter results that came in ahead of the consensus forecast. DXCM shares were up more than 17% at $118.78 by the afternoon today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down more than 1%. The San […]
Better Therapeutics names new chief commercial officer
Better Therapeutics (Nasdaq:BTTX) announced today that it appointed Diane Gomez-Thinnes as its new chief commercial officer (CCO). Gomez-Thinnes’ appointment became effective yesterday, Oct. 26, 2022. She joins the San Francisco-based company, which develops prescription digital therapeutics (PDTs). They use a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, […]
Insulet CEO Jim Hollingshead talks leadership in a time of change
Insulet (Nasdaq:PODD) CEO Jim Hollingshead says his current field in some ways marks his third different career path. He began as an academic, then went into consulting. The former ResMed executive took over in the corner office at Insulet following CEO Shacey Petrovic’s departure for personal reasons earlier this year. He’s served on Insulet’s board since […]
How Dexcom uses wearables to deliver differentiated diabetes management
Dexcom (Nasdaq:DXCM) is one of the leaders in the diabetes technology space with its continuous glucose monitoring (CGM) technology. The company’s current-generation Dexcom G6 CGM remains one of the biggest players in the CGM space. Meanwhile, its next-generation Dexcom G7 CGM has already launched in a number of countries overseas. The wearable device — which […]
Baxter’s smart incontinence pad system has an RF problem
Baxter (NYSE: BAX) recently announced an Urgent Medical Device Correction for its WatchCare incontinence management system. The Oct. 21 announcement said that the WatchCare system was meant to comply with the most recent radio frequency standards. However, it appears to radiate RF that may affect other devices on caregivers and patients. In all but two […]